These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24801479)

  • 81. Updated UK Recommendations for HER2 assessment in breast cancer.
    Rakha EA; Pinder SE; Bartlett JM; Ibrahim M; Starczynski J; Carder PJ; Provenzano E; Hanby A; Hales S; Lee AH; Ellis IO;
    J Clin Pathol; 2015 Feb; 68(2):93-9. PubMed ID: 25488926
    [TBL] [Abstract][Full Text] [Related]  

  • 82. External quality assessment in the absence of proficiency testing: A split-sample testing program experience.
    Guiñón L; García-Villoria J; Ribes A; Gort L; Molina A; Soler A; Sahuquillo Á; Alvarez L
    Clin Biochem; 2021 Nov; 97():78-81. PubMed ID: 34329621
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Optimizing hepcidin measurement with a proficiency test framework and standardization improvement.
    Aune ET; Diepeveen LE; Laarakkers CM; Klaver S; Armitage AE; Bansal S; Chen M; Fillet M; Han H; Herkert M; Itkonen O; van de Kerkhof D; Krygier A; Lefebvre T; Neyer P; Rieke M; Tomosugi N; Weykamp CW; Swinkels DW
    Clin Chem Lab Med; 2020 Oct; 59(2):315-323. PubMed ID: 33001847
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN).
    Lourens C; Lindegardh N; Barnes KI; Guerin PJ; Sibley CH; White NJ; Tarning J
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3889-94. PubMed ID: 24777099
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Educational antimicrobial susceptibility testing as a critical component of microbiology laboratory proficiency programs: American Proficiency Institute results for 2007-2011.
    Jones RN; Glick T; Sader HS; Flamm RK; Ross JE; Rhomberg PR; Edson DC
    Diagn Microbiol Infect Dis; 2013 Apr; 75(4):357-60. PubMed ID: 23481025
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Design of Analytical Run Length for Clinical Chemistry Analytes.
    Hu L; Wang W; Xiao Y; Wang Z
    Clin Lab; 2015; 61(8):891-7. PubMed ID: 26427131
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Continuing global improvement in human papillomavirus DNA genotyping services: The 2013 and 2014 HPV LabNet international proficiency studies.
    Eklund C; Forslund O; Wallin KL; Dillner J
    J Clin Virol; 2018 Apr; 101():74-85. PubMed ID: 29433017
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Towards harmonization of external quality assessment/proficiency testing in hemostasis.
    Favaloro EJ; Jennings I; Olson J; Van Cott EM; Bonar R; Gosselin R; Meijer P
    Clin Chem Lab Med; 2018 Dec; 57(1):115-126. PubMed ID: 29668440
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
    Holland DT; DiFrancesco R; Connor JD; Morse GD
    Ther Drug Monit; 2006 Jun; 28(3):367-74. PubMed ID: 16778721
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay.
    Dobbs T; Liu X; Anderson R; Nkengasong J; Parekh BS
    J Clin Microbiol; 2011 Oct; 49(10):3470-3. PubMed ID: 21832016
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Detecting reagent lot shifts using proficiency testing data.
    Tan RZ; Punyalack W; Graham P; Badrick T; Loh TP
    Pathology; 2019 Dec; 51(7):711-717. PubMed ID: 31607378
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Harmonization of laboratory results by data adjustment in multicenter clinical trials.
    Lee SG; Chung HJ; Park JB; Park H; Lee EH
    Korean J Intern Med; 2018 Nov; 33(6):1119-1128. PubMed ID: 29065441
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Optimization and evaluation of Luminex performance with supernatants of antigen-stimulated peripheral blood mononuclear cells.
    Surenaud M; Manier C; Richert L; Thiébaut R; Levy Y; Hue S; Lacabaratz C
    BMC Immunol; 2016 Nov; 17(1):44. PubMed ID: 27835944
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Transferring Luminex® cytokine assays to a wall-less plate technology: Validation and comparison study with plasma and cell culture supernatants.
    Versteeg L; Le Guezennec X; Zhan B; Liu Z; Angagaw M; Woodhouse JD; Biswas S; Beaumier CM
    J Immunol Methods; 2017 Jan; 440():74-82. PubMed ID: 27840065
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Variables that affect assays for plasma cytokines and soluble activation markers.
    Aziz N; Nishanian P; Mitsuyasu R; Detels R; Fahey JL
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):89-95. PubMed ID: 9874670
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Guidance for laboratories performing molecular pathology for cancer patients.
    Cree IA; Deans Z; Ligtenberg MJ; Normanno N; Edsjö A; Rouleau E; Solé F; Thunnissen E; Timens W; Schuuring E; Dequeker E; Murray S; Dietel M; Groenen P; Van Krieken JH; ;
    J Clin Pathol; 2014 Nov; 67(11):923-31. PubMed ID: 25012948
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL.
    Dufraing K; Fenizia F; Torlakovic E; Wolstenholme N; Deans ZC; Rouleau E; Vyberg M; Parry S; Schuuring E; Dequeker EMC;
    Virchows Arch; 2021 Mar; 478(3):553-565. PubMed ID: 33047156
    [TBL] [Abstract][Full Text] [Related]  

  • 98. CAP/ACMG proficiency testing for biochemical genetics laboratories: a summary of performance.
    Oglesbee D; Cowan TM; Pasquali M; Wood TC; Weck KE; Long T; Palomaki GE
    Genet Med; 2018 Jan; 20(1):83-90. PubMed ID: 28661487
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Report on HbA1c Proficiency Testing in Asia in 2012.
    Umemoto M; Hoshino T; Miyashita T; Tani W; Kuwa K
    Ann Lab Med; 2015 May; 35(3):352-5. PubMed ID: 25932445
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Quality Control of Busulfan Plasma Quantitation, Modeling, and Dosing: An Interlaboratory Proficiency Testing Program.
    McCune JS; Punt AM; Yeh RF; Dupuis LL; Kweekel DM; Franssen EJF; Ritchie JC; van Maarseveen E; Huitema ADR
    Ther Drug Monit; 2021 Oct; 43(5):657-663. PubMed ID: 33675302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.